• IHTC Helping Kenyans

    A person living in the U.S. diagnosed with hemophilia can still lead a normal life, but that’s not the case for patients in developing countries. The Indiana Hemophilia and Thrombosis Center is on a mission to change that for people living in Kenya, where there was little to no treatment available until the center came along.

  • Catalent Sees Growth in Emerging Biologics Sector

    A year-and-a-half after entering Indiana’s life-sciences environment, New Jersey-based Catalent says the emerging biologics sector is driving big investment in Bloomington. Catalent General Manager Denis Johnson joins us to explain what’s driving the growth and what’s next for the company.

  • BioCrossroads Looking to the Future During Transition

    The incoming interim president and chief executive officer of BioCrossroads says the transition in leadership will be a smooth one. The state's life science initiative announced Wednesday longtime CEO David Johnson is leaving to continue his role as CEO of the Central Indiana Corporate Partnership on a full-time basis. Nora Doherty will assume the interim position at the beginning of the year and says BioCrossroads continues to look to the future.

  • BioCrossroads Announces Watanabe Winner, New Seed Fund

    Indiana University Associate Vice President for Clinical Affairs Anantha Shekhar is the 2018 Watanabe Life Sciences Champion of the Year. BioCrossroads made the announcement today at its annual Life Sciences Summit in Indianapolis. Shekhar is leading the $120 million Precision Health Grand Challenges effort. 

  • Roche Academy Developing Talent Pipeline

    Roche Diagnostics is thinking differently and more creatively to attract talent. This October, the Roche Academy will debut as a custom talent pipeline for biomedical equipment technicians.

  • Elanco Spinoff Perspective

    Eli Lilly and Co. plans to spin off Greenfield-based Elanco Animal Health as a separate company.  UIndy Associate Professor of Finance?Matt?Will explains why he thinks the IPO decision is "long overdue."

  • Indiana CTSI Lands $33M Grant to Improve Health

    The Indiana Clinical and Translational Sciences Institute has received a $33 million boost from the National Institutes of Health. The center’s founder discusses how the funding aims to reverse Indiana’s poor state of health and the need for public’s help.

  • Cook, Fishers Mayor Discuss Leadership, Entrepreneurship

    An event Wednesday at the Indiana IoT Lab in Fishers showcased one of Indiana's highest-profile life sciences companies. Fishers Mayor Scott Fadness hosted Bloomington-based Cook Group Inc. Chairman Steve Ferguson and Cook Group President Pete Yonkman for a discussion on executive leadership. Yonkman says the event offered an opportunity to learn more about innovation and entrepreneurship at the IoT lab and nearby Launch Fishers coworking space.

  • 16 Tech Taps Former LDI Exec For COO

    16 Tech Community Corp. has named Emily Krueger chief operating officer. She previously served as vice president of administration for Indianapolis-based LDI LTD. The organization is the operating entity of the high-profile, 60-acre 16 Tech innovation district coming together on the city's near west side. Krueger will help lead development efforts.

  • Manchester University Touts Unique Pharma Offering

    The director of pharmacogenomics education at Manchester University says a first-of-its-kind in the nation offering could double or triple the number of pharmacists in the country with pharmacogenomics expertise. David Kisor said in our most recent edition of Life Sciences Indiana the dual doctor of pharmacy and master of pharmacogenomics program could help reduce the occurrence of adverse drug reactions.

  • 16 Tech Moving Forward

    A new 60-acre innovation community planned near downtown Indianapolis receives a major boost needed to become reality. 16 Tech lands nearly $40 million and its first developer agreement. Details on what could be a transformative project.

  • Ascus Biosciences Pioneering an Emerging Science

    Indianapolis tech start-up Ascus is pioneering an emerging science, Endomicrobial Ecology, that uses a natural approach to improve animal health and performance. It’s being driven by former Elanco VP of Global Research and Development William Weldon. Endomicrobial Ecology harvests the natural microbiota that already exists in an animal’s system. The research is driving the science behind Ascus’ first product which will launch in Argentina in 2018.

  • Ethanol Industry Key Economic Driver in Indiana

    The chief executive officer from one of the country's foremost biofuel trade associations, says the ethanol industry is a "big part" of the state's economy. Indiana is the nation's fifth largest producer of ethanol, a renewable, earth-friendly biofuel made from feedstock, primarily corn. Inside INdiana Business talks to Growth Energy Chief Executive Officer Emily Skor about the economic and environmental benefits of using ethanol fuel. 

  • Elanco's Future, Lilly Investing in Insulin

    Lilly is doubling down on diabetes. Manufacturing President Maria Crowe talks about plans for a $72 million investment in Indianapolis and weighs-in on what the future holds for animal health unit Elanco.

  • 'Catalyst' Caine Wins Watanabe Award

    Marion County Public Health Department Director Virginia Caine is this year's Watanabe Life Sciences Champion of the Year. BioCrossroads presented the annual award this morning at the Life Sciences Summit in Indianapolis. The organization calls Caine an "ardent voice for public health and access to medical care for the disadvantaged."

  • 16 Tech's New CEO

    A planned 60-acre innovation district on the near west side of Indianapolis has a new leader. 16 Tech has named Bob Coy its first president and CEO.

  • Lilly, Purdue Partner on Life Sciences Research

    Eli Lilly and Co. and Purdue University are forming a strategic life sciences research collaboration. Lilly will provide up to $52 million to fund research over five years, marking Purdue's largest strategic collaboration with a single company.

  • Health Commissioner Discusses Making Opioid Overdose Medication Available Without Prescription

    Tackling overdoses head-on. A lifesaving medication that can reverse opioid overdoses is now available without a prescription. State Health Commissioner Dr. Jerome Adams discusses the importance of Naloxone.

  • 16 Tech Announces First Leader

    Bob Coy has been named first president and chief executive officer of 16 Tech Community Corp. Coy most recently served as CEO of Ohio-based venture development organization CincyTech, which pumped more than $680 million into 70 different startups during his 11 years at the helm. Coy says his top priorities will include construction projects and the continued push for top interdisciplinary talent The 60-acre innovation community located near IUPUI.

  • Biomedical Innovation Center Director Talks Growth

    The Indiana Center for Biomedical Innovation has been a huge success with 11 startup companies under one roof creating an ecosystem for entrepreneurship, technology development and commercialization. The center’s director discusses its growth and plans for expansion.

  • Inside IU's Grand Challenges Winner

    The Precision Health Initiative is the winner of IU’s Grand Challenge. In the Business of Health, IU’s VP of Research shares how the initiative could transform health, medical research and education.

  • Quantum Leap Bridging Humanities and STEM

    Indiana Humanities is launching a new two-year initiative called “Quantum Leap.” CEO Keira Amstutz explains what happens when we bridge the humanities with STEM. 

  • Lilly CEO Details $850M Plans

    Eli Lilly and Co. is making an $850 million investment on manufacturing and research in the U.S. in 2017 and that includes Indianapolis. CEO Dave Ricks talks about what’s fueling the investment, and if more could be on the way.

  • Lilly Diabetes to Sponsor NASCAR

    What do Eli Lilly and Co. and NASCAR have in common? A lot, these days. The Indianapolis-based pharmaceutical company is expanding its partnership, signing a multi-year deal to become the “Official Diabetes Health Partner of NASCAR.”

  • Research Pegs Indiana's Life Sciences Impact at $63B

    The state's life sciences initiative says the industry's impact continues to get bigger. BioCrossroads says research from the Indiana Business Research Center at the Indiana University Kelley School of Business shows the industry's economic impact in 2015 rose to $63 billion. In all, more than 56,000 employees are tied to nearly 1,700 Indiana life sciences companies.

  • Women in Healthcare, Life Sciences Mentoring Program

    There is a scarcity of women leading healthcare and life science organizations in Indiana and across the U.S. Leaders from the Healthcare Businesswomen’s Association Indiana chapter are out to change that with a new mentoring program.   

  • How Upland's Sour Ale Mystery was Solved

    Bloomington-based Upland Brewing Co. was forced to dump 1,600 gallons of beer, because of a fermentation problem. We explain how an IU biochemist came to the rescue. 

  • Roche CEO: IBRI Will Succeed Where Others Have Failed

    The chief executive officer of Roche Diagnostic North America says Governor Eric Holcomb's endorsement of the Indiana Biosciences Research Institute is key to the collaboration that he believes will ultimately make the facility a global leader. Jack Phillips tells Inside INdiana Business the institute is about halfway to its $350 million funding goal. 

  • New Fat Replacement 'Epogee' Lands Major Customer

    Is it too good to be true? A former Dow AgroSciences and Lilly exec has developed a new fat replacement called Epogee that cuts calories, but keeps the taste. Choco Finesse has also landed a first major customer.

  • Purdue's $250M Life Sciences Investment

    Purdue is pumping $250 million into life sciences research. Executive Vice President For Research and Partnerships Suresh Garimella weighs-in on the impact the investment will have on both the university and the state.

  • Inside the Brown Center for Immunotherapy

    The IU School of Medicine receives its largest gift ever from an alum… $30 million! In the Business of Health, Barbara Lewis talks with tech pioneer Don Brown about the gift and a focus on immunotherapy.

  • Outgoing Lilly CEO Talks Triumphs, Disappointments

    Eli Lilly and Co. CEO John Lechleiter sits down for his last interview before leaving the drug maker’s top office. He talks about triumphs, the Alzheimer’s disappointment and what’s next for him and wife Sarah as they head into retirement.

  • Apexian Develops Pancreatic Cancer Drug

    Pancreatic cancer is the fourth leading cause of cancer-related death in the U.S. Barbara Lewis talks with the scientific founder of Apexian Pharmaceuticals about a drug that could make a difference.

  • New AgBiosciences Talent Report

    AgriNovus Indiana is out with a new report on talent. Find out why Indiana is in a good position, and where work needs to be done.

  • Roche's Major Upgrades, Commitment to Indy

    The first phase of a $300 million expansion at Indianapolis-based Roche Diagnostics Corp. is now complete. Hear from the Roche Group chairman, in town from Switzerland, on what he thinks about Indiana.

  • Elanco Establishing Itself as Industry Leader

    Greenfield-based Elanco U.S. Inc. has announced an agreement to add the companion animal vaccine portfolio of one of its competitors. The $885 million deal with Boehringer Ingelheim Vetmedica Inc. involves dozens of cat, dog and rabies vaccines, as well as an Iowa manufacturing facility. Shawn McKee, Elanco's Senior Director of Companion Animal U.S. explains what the planned acquisition will mean for the company. 

  • IBRI Hires European Bioscience Giant

    The Indiana Biosciences Research Institute has hired the man who will set the agenda for the research and innovation that comes out of the center. Rainer Fischer, who has been named chief scientific and innovation officer, most recently led the Fraunhofer Institute for Molecular Biology and Applied Ecology in Germany.

  • Indiana Conference Continues to Connect Life Sciences Industry to Businesses

    The Indiana Life Sciences Collaboration Conference Series kicked off 10 years ago. The popular event continues to serve as a major business connector for the Indiana life sciences industry.

  • Indiana Schools Provide Solution to EpiPen Price Controversy

    The price controversy over the EpiPen has Indiana physicians reminding parents of a recent state law that could help their children. Two years ago, state legislation allowed schools to get EpiPens for free.  

  • Inside Wild Pitch Yeast

    He’s a cancer researcher by day and a beer expert by night. Meet the IU scientist who’s launched Wild Pitch Yeast and is providing yeast to craft breweries making special Bicentennial-ales. 

  • 2016 ‘Indiana Companies to Watch’

    Fourteen businesses state-wide were recognized as the 2016 ‘Indiana Companies to Watch’. Newly appointed Indiana Economic Development Corporation Vice President and Chief Innovation Officer Ian Steff talks about the importance of the event to Governor Mike Pence’s $1 billion innovation and entrepreneurship initiative.

  • 2016 ‘Indiana Companies to Watch’

    Fourteen businesses state-wide were recognized as the 2016 ‘Indiana Companies to Watch’. Newly appointed Indiana Economic Development Corporation Vice President and Chief Innovation Officer Ian Steff talks about the importance of the event to Governor Mike Pence’s $1 billion innovation and entrepreneurship initiative.

  • Anthem-Cigna Merger Prompts Questions

    Indianapolis-based Anthem has announced plans to acquire Cigna for $54 Billion. IU McKinney School of Law Professor Dr. David Orentlicher discusses the details of the deal and what consumers can expect.
  • State Approves HIP 2.0

    The state of Indiana has received approval to implement HIP 2.0 instead of Medicaid. Indiana Hospital Association Vice President of Government Relations Brian Tabor explains the program, which offers health care access to 350,000 uninsured Hoosiers.
  • Lilly Diabetes Making 'Significant' Global Inroads

    Lilly Diabetes President Enrique Conterno says a recent $1 billion investment in insulin manufacturing, half of which is in central Indiana, is paying off. Conterno says the unit is making inroads in major global markets, including China and Japan.